Ardelyx
ARDX
#4876
Rank
NZ$3.10 B
Marketcap
NZ$12.77
Share price
-2.04%
Change (1 day)
32.68%
Change (1 year)

Market capitalization of Ardelyx (ARDX)

Market cap: NZ$3.10 Billion

As of February 2026 Ardelyx has a market cap of NZ$3.10 Billion. This makes Ardelyx the world's 4876th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ardelyx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.10 B28.83%
2025NZ$2.40 B10.06%
2024NZ$2.18 B-3.86%
2023NZ$2.27 B170.46%
2022NZ$0.84 B363.46%
2021NZ$0.18 B-78.37%
2020NZ$0.83 B-15.2%
2019NZ$0.98 B493.27%
2018NZ$0.16 B-62.23%
2017NZ$0.44 B-54.44%
2016NZ$0.96 B41.06%
2015NZ$0.68 B53.38%
2014NZ$0.44 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Ardelyx was reported to be:

NZ$3.10 Billion
by Nasdaq info icon info icon
NZ$3.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
NZ$315.86 B 10,081.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$305.67 B 9,752.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$189.70 B 6,014.89%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
NZ$477.59 B 15,294.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
NZ$1.66 B-46.47%๐Ÿ‡บ๐Ÿ‡ธ USA